Novo Nordisk Reports Cybersecurity Incident Involving Patient Data Breach

On June 11, 2026, Novo Nordisk announced a cybersecurity incident involving unauthorized access to its internal IT systems. The breach included the copying of non-public personal data related to patients participating in clinical trials, although this data is not directly linked to any individuals. The company has engaged external cybersecurity experts and is cooperating with relevant authorities to investigate the incident. As a precaution, several internal IT systems were temporarily taken offline, but core business operations remain unaffected. Novo Nordisk is notifying impacted parties and has advised patients to remain vigilant for any unusual occurrences. The specific categories of data affected may include patient ID, year of birth, sex, and health data. The company does not consider the incident to pose immediate risks to patients.

Key Points: • Unauthorized access to internal IT systems at Novo Nordisk confirmed on June 11, 2026. • Non-public personal data from clinical trials was copied, but not directly linked to individuals. • Core operations remain unaffected; affected systems are being restored safely.